Cargando…

Milrinone for the treatment of heart failure caused by severe Pneumonia in children with congenital heart disease: a meta-analysis

BACKGROUND: Children with congenital heart disease (CHD) are easily complicated by severe pneumonia and heart failure. We aimed to conduct a meta-analysis to evaluate the effects and safety of milrinone for the treatment of heart failure caused by severe pneumonia in children with CHD to provide evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Wenshen, Diao, Shuangshuang, Zhou, Lu, Cai, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612214/ https://www.ncbi.nlm.nih.gov/pubmed/37891490 http://dx.doi.org/10.1186/s12887-023-04360-z

Ejemplares similares

Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022)

Repetitive milrinone therapy in ambulatory advanced heart failure patients
por: Laufer‐Perl, Michal, et al.
Publicado: (2022)

Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure
por: Lanfear, David E, et al.
Publicado: (2009)

Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2020)

Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022)

Old Drug, New Trick? Oral Milrinone for Heart Failure With Preserved Ejection Fraction
por: Silverman, Daniel N., et al.
Publicado: (2020)

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
por: Rodenas‐Alesina, Eduard, et al.
Publicado: (2023)

Does Inhaled Milrinone Facilitate Weaning From Cardiopulmonary Bypass in Children with Congenital Heart Diseases Complicated with Pulmonary Arterial Hypertension?
por: Elbaser, Ibrahim Ibrahim Abd, et al.
Publicado: (2020)

Milrinone: Treatment failure: case report
Publicado: (2020)

Effects of milrinone on serum IL-6, TNF-α, Cys-C and cardiac functions of patients with chronic heart failure
por: Shao, Tingguo, et al.
Publicado: (2018)

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
por: Matsumoto, Shuhei, et al.
Publicado: (2012)

The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
por: Del Rio-Pertuz, Gaspar, et al.
Publicado: (2023)

Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion
por: Huang, Ming-He, et al.
Publicado: (2011)

Safety and Efficacy of the Off-Label Use of Milrinone in Pediatric Patients with Heart Diseases
por: Lee, Joowon, et al.
Publicado: (2014)

Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018)

Acute Severe Heart Failure in a Child With Congenital Heart Defect and Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Pawar, Ravindra S., et al.
Publicado: (2021)

Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure
por: Chowdhury, Biswajit, et al.
Publicado: (2017)

Arrhythmias in adults with congenital heart disease and heart failure
por: Bessière, Francis, et al.
Publicado: (2021)

Editorial: Heart Failure in Pediatrics and Congenital Heart Disease
por: Azeka, Estela, et al.
Publicado: (2022)

Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure
por: Lukasz, Alexander, et al.
Publicado: (2013)

Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reports
por: Li, Wanli, et al.
Publicado: (2016)

Milrinone role in treatment of septic shock
por: Tomicic, V, et al.
Publicado: (2015)

Milrinone, we all like you …
por: Januszewska, Katarzyna
Publicado: (2023)

Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease–Related Heart Failure
por: Burchill, Luke J., et al.
Publicado: (2018)

Congenital coronary artery fistulae: a rare cause of heart failure in adults
por: Geller, Charles M, et al.
Publicado: (2014)

Para-Hisian atrial tachycardia: A neglected cause of severe heart failure in children
por: Tarek, Aliaa, et al.
Publicado: (2022)

Incidence and Outcomes of Advanced Heart Failure in Adults With Congenital Heart Disease
por: Egbe, Alexander C., et al.
Publicado: (2022)

Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19
por: Vogel, Dominik J., et al.
Publicado: (2021)

Right ventricular failure in congenital heart disease
por: Cho, Young Kuk, et al.
Publicado: (2013)

Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
por: Abdel-Razek, Omar, et al.
Publicado: (2023)

Milrinone in Enterovirus 71 Brain Stem Encephalitis
por: Wang, Shih-Min
Publicado: (2016)

Continuous Intravenous Milrinone Therapy in Pediatric Outpatients
por: Curley, Michelle, et al.
Publicado: (2017)

Asplenia in children with congenital heart disease as a cause of poor outcome
por: Erdem, Semiha Bahceci, et al.
Publicado: (2015)

Value of Galectin-3 assay in children with heart failure secondary to congenital heart diseases: a prospective study
por: Saleh, Nagwan, et al.
Publicado: (2020)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Andersen, Stine, et al.
Publicado: (2016)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

Heart Murmur in Neonates: How Often Is It Caused by Congenital Heart Disease?
por: Mirzarahimi, Mehrdad, et al.
Publicado: (2011)

Heart Failure in Children
por: Jayaprasad, N.
Publicado: (2016)

Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices
por: Akhtar, Waqas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q0m57o5q1upq421de46uvv1jku